4.0 Review

The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia Two Roads Converged

Journal

ARCHIVES OF NEUROLOGY
Volume 66, Issue 3, Pages 300-305

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneurol.2009.27

Keywords

-

Funding

  1. Department of Veterans Affairs
  2. National Institutes of Health [RO1 AG023801]
  3. NATIONAL INSTITUTE ON AGING [R01AG023801] Funding Source: NIH RePORTER

Ask authors/readers for more resources

In recent years a rapidly increasing number of studies has focused on the relationship between dementia and metabolic disorders such as diabetes, obesity, hypertension, and dyslipidemia. Etiological heterogeneity and comorbidity pose challenges for determining relationships among metabolic disorders. The independent and interactive effects of brain vascular injury and classic pathological agents such as beta-amyloid have also proved difficult to distinguish in human patients, blurring the lines between Alzheimer disease and vascular dementia. This review highlights recent work aimed at identifying convergent mechanisms such as insulin resistance that may underlie comorbid metabolic disorders and thereby increase dementia risk. Identification of such convergent factors will not only provide important insight into the causes and interdependencies of late-life dementias but will also inspire novel strategies for treating and preventing these disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available